July 2, 2021

Volume XI, Number 183

Advertisement

July 01, 2021

Subscribe to Latest Legal News and Analysis

June 30, 2021

Subscribe to Latest Legal News and Analysis

June 29, 2021

Subscribe to Latest Legal News and Analysis

Intellectual Property, Patent, Trademark and Copyright Law News

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as  an ex parte appeal from denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent-filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade-secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

Date Title Organization
1
Jul
Ready, Set, Go: Crystalize Your Thinking Finnegan
1
Jul
Patent Owner Tip #11 for Surviving an Instituted IPR: Use It or Lose It (in the POR) Mintz
1
Jul
To Be Fair, the Supreme Court Grants Assignor Estoppel a Reprieve but Limits Its Scope McDermott Will & Emery
1
Jul
What Will Arthrex Review Look Like? Foley & Lardner LLP
1
Jul
Supreme Court Rules that Inventors Can Contest the Validity of Patents After Assigning Them Proskauer Rose LLP
1
Jul
Federal Circuit Says No to Incorporating Argument by Reference Finnegan
1
Jul
BEST MODE: Did You, or Are You Just Going To, Test that Invention? Squire Patton Boggs (US) LLP
30
Jun
Supreme Court Adds New Wrinkle to Patent Inter Partes Review Proceedings, But Actual Impact Remains Unclear Miller Canfield
30
Jun
Court Decision Means that Antibody Patenting Is Not Getting Easier Bradley Arant Boult Cummings LLP
29
Jun
Is Lawful Possession of a Trade Secret Enough for Standing to Sue for Misappropriation? Sheppard, Mullin, Richter & Hampton LLP
29
Jun
TTAB Trims Monster’s Claws by Dismissing Opposition Against Toronto Raptors Logo Finnegan
29
Jun
Amendment to China Patent Law Offer PTA, PTE and Patent Linkage Foley & Lardner LLP
28
Jun
Striking the Balance Between Detailed Description and Unnecessary Disclosure of the “Secret” in Trade Secret Litigation Pleadings Sheppard, Mullin, Richter & Hampton LLP
25
Jun
Is a State Entity Shielded from Liability for Copyright Infringement by Sovereign Immunity? Norris McLaughlin P.A.
24
Jun
Supreme Court Assigns PTO Director a New Gig: Reviewing the PTAB’s Inter Partes Decisions McDermott Will & Emery
24
Jun
Arthrex: PTAB Lives to Fight Another Day with (a Bit) More Oversight [PODCAST] Mintz
24
Jun
Arthrex SCOTUS Ruling: The IPR Show Must Go On, Just with (a Bit) More Oversight Mintz
24
Jun
Patent Owner Tip #10 for Surviving an Instituted IPR: Address Claim Construction and Public Availability Mintz
24
Jun
In United States v. Arthrex, Supreme Court Holds Administrative Patent Judges’ Decisions Must Be Reviewed by the Director of the U.S. Patent and Trademark Office Greenberg Traurig, LLP
24
Jun
What Does it Take to Plead Trade Secret Misappropriation Under the DTSA? McDermott Will & Emery

Pages

Advertisement
Advertisement
Advertisement